The Bernstein test has been in clinical use for over 30 years as a means of reproducing oesophageal pain.' It was originally designed as a test of oesophageal acid sensitivity. It has also been used more recently as a provocative test during oesophageal manometry in patients with noncardiac chest pain.2' Nevertheless, the role of acid perfusion in the elucidation of oesophageal pain has been challenged by the Two of the 50 patients reported their symptoms as being constantly present during pH monitoring and one patient failed to record the timing of symptoms. Therefore, symptomatic reflux could only be assessed in 47 patients (nine with noncardiac chest pain and 38 with suspected reflux).
The patients' usual pain or heartburn was reported by six of the nine patients with noncardiac chest pain and 26 of 38 patients who presented with possible reflux symptoms during ambulatory pH monitoring. The median number of reported pain episodes in both the patients with non-cardiac chest pain and suspected reflux was 2 with ranges of 0 to 20 and 0 to 14-3% had subxiphoid pain, 18-1% had dysphagia, and 9-4% had dyspepsia. Hence, less than half the patients with oesophagitis had symptoms possibly attributable to reflux. We have previously shown that only 60% of patients with oesophagitis had heartburn, regurgitation, or retrosternal chest pain as major presenting complaints.20 Similar difficulties in diagnosing reflux disease on the basis of the history were encountered by Wienbeck and Berges. 8 In the present study, 84% ofpatients had an endoscopically normal oesophagus at the time of referral for ambulatory pH studies. Conversely, the proportion of patients thought to have reflux symptoms who have endoscopic evidence of oesophagitis varies from 40% to 80% in published series.2' -24 The relation between reflux symptoms and abnormal acid exposure also raises further difficulties. We2' and others' have recently shown that reflux symptoms can occur in some patients with normal oesophageal acid exposure times.
We therefore examined the relation between mucosal acid sensitivity, as determined by the acid perfusion test, and both distal oesophageal acid exposure time and symptomatic reflux during ambulatory pH monitoring in patients referred for ambulatory pH studies. Of course, this group is probably not representative of reflux patients as a whole. Nevertheless, patients requiring pH monitoring for the diagnosis of their symptoms constitute a clinically important group. We defined 'symptomatic reflux' as a 50%, or greater, association between the patient's usual symptoms of chest pain or heartburn and reflux events. Since there is some disagreement as to threshold value for this temporal association we also used a threshold symptom -reflux association of 25% as recommended by Hewson et al. The present study confirms that abnormal acid exposure has a low predictive value for both oesophageal acid sensitivity and symptomatic reflux during pH monitoring, as we defined it. All the patients with symptomatic reflux, however, had evidence of mucosal acid sensitivity during acid perfusion when we used a symptom-reflux association of 50%. (However, four of 17 patients with a symptom-reflux association of >25% did not have acid sensitivity.) Therefore, in this group of patients, symptomatic reflux can be explained on the basis of mucosal sensitivity to acid using a threshold symptom-reflux association of 50% 
